Carregant...
Thrombolysis by chemically modified coagulation factor Xa
BACKGROUND: Enzymatic thrombolysis carries the risk of hemorrhage and re-occlusion must be evaded by co-administration with an anticoagulant. Toward further improving these shortcomings, we report a novel dual-functioning molecule, Xai-K, which is both a non-enzymatic thrombolytic agent and an antic...
Guardat en:
| Publicat a: | J Thromb Haemost |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5576980/ https://ncbi.nlm.nih.gov/pubmed/27359348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.13402 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|